Sunday, October 23, 2011
7:55 a.m. - 12:00 p.m.

Ballroom B
Vancouver Convention Centre
West Building
Vancouver, British Columbia

Beyond 2000 Syllabus

Click Here to download a PDF version of the Syllabus

REGISTER NOW

Please help us by registering early.
Pre-conference registrants will have access to post event slides and materials

For questions about registration or this site, please email info@evidencebasedmarketing.ca
For questions about the beyond 2000 program, please contact Jenny Martins at 905-564-7700 / 1-800-578-5581

Host City

On April 6, 1886, the rough-and-tumble west coast timber outpost of Granville was officially incorporated as the City of Vancouver. Two months later, an inferno sparked by a brush fire burned the new city to the ground in 30 minutes. The very next year, the first transcontinental train in the country chugged into the Vancouver terminus, launching a wave of development. The aboriginal population was fueled by immigration and the city grew over the next century from a logging and fishing town into the cosmopolitan world capital it is today.

The year 2011 marks Vancouver's 125th birthday. Surrounded by water on three sides and nestled alongside the Coast Mountain Range, Vancouver is the largest city in the province of British Columbia with over half a million residents and one of the mildest climates in Canada. Home to spectacular natural scenery and a bustling metropolitan core, Vancouver was host city to the 2010 Olympic and Paralympic Winter Games. Visitors, meeting attendees and locals alike can enjoy everything from city pursuits to outdoor thrills and more.

Continuing the Conversation Beyond 2000

The conversation continues with a panel of world renowned experts who discuss topics that range from current trial results and how they impact clinical practice to key differences in treating men and women. Other topics include conversations about Molecular Medicine and its novel approach to treatment and the timing of electrical device implantation for ACS patients.

These conversations should allow you to evaluate the changing epidemiology of ACS, the impact of novel advances in molecular medicine, and the extent to which these are clinically applicable. The implications of sex differences and the increasingly important consequences of bleeding in ACS are discussed as well as the changing role of electrical devices as it applies to the spectrum of patients with acute coronary disease.


Please register to gain access to the following video discussions (Registration is free).

Striding the Seam Between Efficacy and Safety in the Treatment of Acute Coronary Syndromes

Lars Wallentin - Professor of Cardiology, Uppsala University Hospital

Molecular Medicine and Acute Coronary Syndromes: Promises Made, Promises Kept?

Christopher Granger - Professor of Medicine, Duke University

Living Better Electrically: Which Devices for Which Patients and When?

Paul Dorian - Professor of Medicine, University of Toronto

The Female Factor in Acute Coronary Disease: Myths versus Reality

Judith Hochman - Professor of Cardiology, New York University, School of Medicine


Welcome

It is a pleasure to extend a personal invitation to you to attend our 17th annual forward-looking symposium, “New Concepts in Acute Coronary Syndromes: Beyond 2000 (XVII).” This year’s meeting in Canada’s splendid Olympic city, Vancouver, British Columbia, promises to be not only educational, but stimulating and enjoyable. Held as usual on Sunday morning—October 23rd—in conjunction with the annual Canadian Cardiovascular Congress meeting, the event is supported by unrestricted educational grants from AstraZeneca and Merck. We are pleased that they have partnered with the University of Alberta’s continued tradition of addressing key issues in acute cardiovascular medicine. We look forward to welcoming you to this event.

As you can see from the enclosed program, we have a distinguished cadre of thought leaders from Canada and around the world, who will address some of the most relevant and compelling issues in contemporary cardiovascular medicine. Moreover, the interactive panel, case presentations, and opportunity for dialogue will ensure the Faculty and subjects are well grounded to clinical practice.

Importantly, this year a new web site has been launched to facilitate registration and knowledge translation. On this site (www.Beyond2000.org), you can view the program, the Faculty, and advance register for the symposium. Your registration will provide you with regular updates. Upon conclusion of the meeting, the full set of slide presentations and other materials will be available, allowing for topic review and further increasing your learning opportunities.

Beyond2000.org is now available to take your registration. Please join us for a memorable experience. We look forward to seeing you there!



Paul Armstrong, MD